Download video

Dr. Venugopal Highlights Myelofibrosis Research at ASH 2023

256 views

Blood Cancers Today

1 year ago

Dr. Venugopal Highlights Myelofibrosis Research at ASH 2023

Dr. Venugopal Highlights Myelofibrosis Research at ASH 2023

Dr. Venugopal Highlights Myelofibrosis Research at ASH 2023
1:25
Dr. Venugopal Highlights Myelofibrosis Research at ASH 2023
by Blood Cancers Today
Highlights on myelofibrosis from ASH
1:25
Highlights on myelofibrosis from ASH
by VJHemOnc – Video Journal of Hematology \& HemOnc
Reflecting on Myelofibrosis Awareness Day
2:20
Reflecting on Myelofibrosis Awareness Day
by Blood Cancers Today
Bomedemstat for high-risk myelofibrosis
2:51
Bomedemstat for high-risk myelofibrosis
by VJHemOnc – Video Journal of Hematology \& HemOnc
Thalassemia highlights at ASH 2023: novel therapies, trial updates \& the value of precision medicine
11:42
Thalassemia highlights at ASH 2023: novel therapies, trial updates \& the value of precision medicine
by VJHemOnc – Video Journal of Hematology \& HemOnc
2022 ASH Conference - Dr. Ruben Mesa, MD
6:36
2022 ASH Conference - Dr. Ruben Mesa, MD
by MPN Advocacy \& Education International
Key updates in MPNs from ASH 2018
6:57
Key updates in MPNs from ASH 2018
by VJHemOnc – Video Journal of Hematology \& HemOnc
Dr. Anna Halpern on her ASH presentation
1:51
Dr. Anna Halpern on her ASH presentation
by Fred Hutch Patient Care
New Frontiers in Myelofibrosis Care Presented at ASH 2024
9:47
New Frontiers in Myelofibrosis Care Presented at ASH 2024
by Blood Cancers Today
SIMPLIFY studies: analysis of the meaningful symptomatic change in patients with myelofibrosis
0:46
SIMPLIFY studies: analysis of the meaningful symptomatic change in patients with myelofibrosis
by VJHemOnc – Video Journal of Hematology \& HemOnc
The MMyeRisk project: developing minimally invasive methods for staging MGUS and smoldering myeloma
1:25
The MMyeRisk project: developing minimally invasive methods for staging MGUS and smoldering myeloma
by VJHemOnc – Video Journal of Hematology \& HemOnc
Real-world data on the efficacy of luspatercept in LR-MDS
4:00
Real-world data on the efficacy of luspatercept in LR-MDS
by VJHemOnc – Video Journal of Hematology \& HemOnc
A Phase I\/II trial of glofitamab monotherapy in R\/R MCL
1:45
A Phase I\/II trial of glofitamab monotherapy in R\/R MCL
by VJHemOnc – Video Journal of Hematology \& HemOnc
Dr. Garcia on Managing Thrombocytopenia With Navitoclax in Myelofibrosis
1:21
Dr. Garcia on Managing Thrombocytopenia With Navitoclax in Myelofibrosis
by OncLive
Panobinostat in myelofibrosis
1:38
Panobinostat in myelofibrosis
by VJHemOnc – Video Journal of Hematology \& HemOnc
Phase II trial of KER-050 in patients with myelofibrosis
0:50
Phase II trial of KER-050 in patients with myelofibrosis
by VJHemOnc – Video Journal of Hematology \& HemOnc
MPN Updates from ASH19 - Angela Fleischman, MD, PhD
11:46
MPN Updates from ASH19 - Angela Fleischman, MD, PhD
by AAMDSIF
Dr Ruben Mesa-Myelofibrosis and Advancing MPNs: Current and Future Approaches
30:30
Dr Ruben Mesa-Myelofibrosis and Advancing MPNs: Current and Future Approaches
by MPN Advocacy \& Education International
ASM 2018 - Professor Claire Harrison
6:02
ASM 2018 - Professor Claire Harrison
by British Society for Haematology